Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hitoshi Shimano

Showing results (311-320 of 317) with videos related to

Pageof 32
Sort By:
You have reached the last page of results.This site can display upto 317 results.
Nature Cardiovascular Research|December 9, 2024
Clonal hematopoiesis-related mutant ASXL1 promotes atherosclerosis in mice via dysregulated innate immunityNaru Sato, Susumu Goyama, Yu-Hsuan Chang, et al.
Cell Reports|August 23, 2016
KLF15 Enables Rapid Switching between Lipogenesis and Gluconeogenesis during FastingYoshinori Takeuchi, Naoya Yahagi, Yuichi Aita, et al.
Endocrinology|September 19, 2014
Hepatic CREB3L3 controls whole-body energy homeostasis and improves obesity and diabetesYoshimi Nakagawa, Aoi Satoh, Sachiko Yabe, et al.
Endocrinology, Diabetes & Metabolism Case Reports|December 26, 2022
A case of NASH with genetic predisposition successfully treated with an SGLT2 inhibitor: a possible involvement of mitochondrial dysfunctionRikako Nakajima, Motohiro Sekiya, Yasuhisa Furuta, et al.
Journal of Atherosclerosis and Thrombosis|March 27, 2024
Genetic and Functional Analyses of Patients with Marked Hypo-High-Density Lipoprotein CholesterolemiaYasuhisa Furuta, Yoshinori Osaki, Yoshimi Nakagawa, et al.
Mucosal Immunology|January 11, 2022
Intestinal microbe-dependent ω3 lipid metabolite αKetoA prevents inflammatory diseases in mice and cynomolgus macaquesTakahiro Nagatake, Shigenobu Kishino, Emiko Urano, et al.
Cardiovascular Diabetology|June 6, 2019
The selective peroxisome proliferator-activated receptor alpha modulator (SPPARMα) paradigm: conceptual framework and therapeutic potential : A consensus statement from the International Atherosclerosis Society (IAS) and the Residual Risk Reduction Initiative (R3i) FoundationJean-Charles Fruchart, Raul D Santos, Carlos Aguilar-Salinas, et al.
Pageof 32

Showing results (311-320 of 317) with videos related to

Sort By:
Pageof 32
You have reached the last page of results.This site can display upto 317 results.
Nature Cardiovascular Research|December 9, 2024
Clonal hematopoiesis-related mutant ASXL1 promotes atherosclerosis in mice via dysregulated innate immunityNaru Sato, Susumu Goyama, Yu-Hsuan Chang, et al.
Cell Reports|August 23, 2016
KLF15 Enables Rapid Switching between Lipogenesis and Gluconeogenesis during FastingYoshinori Takeuchi, Naoya Yahagi, Yuichi Aita, et al.
Endocrinology|September 19, 2014
Hepatic CREB3L3 controls whole-body energy homeostasis and improves obesity and diabetesYoshimi Nakagawa, Aoi Satoh, Sachiko Yabe, et al.
Endocrinology, Diabetes & Metabolism Case Reports|December 26, 2022
A case of NASH with genetic predisposition successfully treated with an SGLT2 inhibitor: a possible involvement of mitochondrial dysfunctionRikako Nakajima, Motohiro Sekiya, Yasuhisa Furuta, et al.
Journal of Atherosclerosis and Thrombosis|March 27, 2024
Genetic and Functional Analyses of Patients with Marked Hypo-High-Density Lipoprotein CholesterolemiaYasuhisa Furuta, Yoshinori Osaki, Yoshimi Nakagawa, et al.
Mucosal Immunology|January 11, 2022
Intestinal microbe-dependent ω3 lipid metabolite αKetoA prevents inflammatory diseases in mice and cynomolgus macaquesTakahiro Nagatake, Shigenobu Kishino, Emiko Urano, et al.
Cardiovascular Diabetology|June 6, 2019
The selective peroxisome proliferator-activated receptor alpha modulator (SPPARMα) paradigm: conceptual framework and therapeutic potential : A consensus statement from the International Atherosclerosis Society (IAS) and the Residual Risk Reduction Initiative (R3i) FoundationJean-Charles Fruchart, Raul D Santos, Carlos Aguilar-Salinas, et al.
Pageof 32